105 related articles for article (PubMed ID: 7673861)
1. Modified lipoproteins in diabetes.
Böttiger LE
J Intern Med; 1995 Sep; 238(3):293. PubMed ID: 7673861
[No Abstract] [Full Text] [Related]
2. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation.
Tertov VV; Orekhov AN; Sobenin IA; Gabbasov ZA; Popov EG; Yaroslavov AA; Smirnov VN
Circ Res; 1992 Jul; 71(1):218-28. PubMed ID: 1606664
[TBL] [Abstract][Full Text] [Related]
3. Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus.
Sánchez-Quesada JL; Pérez A
Endocrinol Nutr; 2013 Nov; 60(9):518-28. PubMed ID: 23545115
[TBL] [Abstract][Full Text] [Related]
4. [Immune response against modified low-density lipoproteins in patients with non-insulin-dependent diabetes mellitus].
González M; Rojas N; Durán D; Schade A; Campos R; Milos C
Rev Med Chil; 1997 Aug; 125(8):879-85. PubMed ID: 9567390
[TBL] [Abstract][Full Text] [Related]
5. Modified fluidity and lipid composition in lipoproteins and platelet membranes from diabetic patients.
Rabini RA; Ferretti G; Galassi R; Taus M; Curatola G; Tangorra A; Fumelli P; Mazzanti L
Clin Biochem; 1994 Oct; 27(5):381-5. PubMed ID: 7867216
[TBL] [Abstract][Full Text] [Related]
6. Modified lipoproteins in diabetes.
Deslypere JP
J Intern Med Suppl; 1994; 736():69-74. PubMed ID: 7986312
[TBL] [Abstract][Full Text] [Related]
7. [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].
Actis Dato SM; Rebolledo OR
Medicina (B Aires); 2000; 60(5 Pt 1):645-56. PubMed ID: 11188909
[TBL] [Abstract][Full Text] [Related]
8. Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes.
Yu JY; Du M; Elliott MH; Wu M; Fu D; Yang S; Basu A; Gu X; Ma JX; Aston CE; Lyons TJ
Diabetologia; 2016 Sep; 59(9):2026-35. PubMed ID: 27306616
[TBL] [Abstract][Full Text] [Related]
9. Platelets and the lipoproteins: native, modified and platelet modified lipoproteins.
Malle E; Sattler W
Platelets; 1994; 5(2):70-83. PubMed ID: 21043607
[TBL] [Abstract][Full Text] [Related]
10. Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and/or hyperlipidemic hamster.
Sima A; Popov D; Starodub O; Stancu C; Cristea C; Stern D; Simionescu M
Lab Invest; 1997 Jul; 77(1):3-18. PubMed ID: 9251674
[TBL] [Abstract][Full Text] [Related]
11. [Lipoprotein and apoprotein changes in type-2 diabetes mellitus].
Dobrev D; Terzieva Ts; Krŭstev I; Petrova V; Ivanov I
Vutr Boles; 1988; 27(5):24-8. PubMed ID: 3213033
[TBL] [Abstract][Full Text] [Related]
12. Modified lipoproteins provide lipids that modulate dendritic cell immune function.
Perrin-Cocon L; Diaz O; André P; Lotteau V
Biochimie; 2013 Jan; 95(1):103-8. PubMed ID: 22959067
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
Laakso M; Pyörälä K
Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
[TBL] [Abstract][Full Text] [Related]
15. [Glycosylated lipoproteins as atherogenic factor in diabetes (review of the literature)].
Denisenko TV
Vopr Med Khim; 1990; 36(2):5-10. PubMed ID: 2194367
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis.
De Man FH; Cabezas MC; Van Barlingen HH; Erkelens DW; de Bruin TW
Eur J Clin Invest; 1996 Feb; 26(2):89-108. PubMed ID: 8904518
[TBL] [Abstract][Full Text] [Related]
17. A modified method for phenotyping of hyperlipoproteinaemia on agarose electrophoresis.
Van Melsen A; De Greve Y; Vanderveiken F; Vastesaeger M; Blaton V; Peeters H
Clin Chim Acta; 1974 Sep; 55(2):225-34. PubMed ID: 4376472
[No Abstract] [Full Text] [Related]
18. [Not Available].
Saha S; Bornstein SR; Graessler J; Chakrabarti S; Kopprasch S
Horm Metab Res; 2017 Sep; 49(9):716-718. PubMed ID: 28834964
[TBL] [Abstract][Full Text] [Related]
19. Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet function.
Opper C; Schüssler G; Sattler W; Malle E
Platelets; 1998; 9(5):339-41. PubMed ID: 16793758
[TBL] [Abstract][Full Text] [Related]
20. [BETA-LIPOPROTEINS IN CHILDHOOD. STUDIES ON CHILDREN WITH NORMAL METABOLISM, DIABETES AND NEPHROSIS].
ROSENKRANZ A; WEIPPL G
Wien Klin Wochenschr; 1964 Jan; 76():24-5. PubMed ID: 14125765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
